Emulate

Boston, MA · Founded 2013 · Privately Held (backing)

Developer of organ-on-a-chip technology designed to predict human response with greater precision and detail than other experimental testing methods. Emulate is based in Boston, MA and was founded in 2013. It was valued at $140 million at its later-stage round in Mar 2024, the last priced event on record. It has raised $278 million across 7 recorded rounds; the latest was a $57.5 million later-stage round in Aug 2021.

PMV mark · valuation
$140.0M
Oct 2026
Priced at
its later-stage round
Mar 2024
Total raised
$278.4M
Last round
Later Stage VC
Aug 2021
Cap table — not yet on record

Emulate's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Emulate with a free account
  • ·The complete investor list: 33 names
  • ·Watch Emulate: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Emulate

Where does Emulate's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Emulate's 7 recorded funding rounds.